ZOSANO PHARMA CORP. Daily Stock Analysis

Daily Stock Analysis, ZSL, ZOSANO PHARMA CORP, priceseries

ZOSANO PHARMA CORP. Daily Stock Analysis
Stock Information
Open
21.20
Close
20.94
High
21.39
Low
20.82
Previous Close
21.01
Daily Price Gain
-0.07
YTD High
29.86
YTD High Date
Jan 6, 2022
YTD Low
20.82
YTD Low Date
Mar 7, 2022
YTD Price Change
-6.79
YTD Gain
-24.49%
52 Week High
33.18
52 Week High Date
Sep 29, 2021
52 Week Low
19.90
52 Week Low Date
Jun 1, 2021
52 Week Price Change
-5.98
52 Week Gain
-22.21%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 6. 2017
122.44
Mar 15. 2017
129.06
7 Trading Days
5.41%
Link
LONG
Apr 19. 2017
116.12
May 15. 2017
134.84
18 Trading Days
16.12%
Link
LONG
Sep 15. 2017
117.94
Oct 6. 2017
129.38
15 Trading Days
9.70%
Link
LONG
Nov 28. 2017
127.44
Dec 13. 2017
139.00
11 Trading Days
9.07%
Link
LONG
Jun 15. 2018
129.72
Jul 9. 2018
136.64
15 Trading Days
5.33%
Link
LONG
Aug 10. 2018
152.44
Aug 24. 2018
163.08
10 Trading Days
6.98%
Link
LONG
Feb 27. 2019
144.83
Mar 8. 2019
152.88
7 Trading Days
5.56%
Link
LONG
Nov 5. 2019
110.48
Nov 19. 2019
117.03
10 Trading Days
5.93%
Link
LONG
Mar 10. 2020
117.04
Mar 23. 2020
168.69
9 Trading Days
44.13%
Link
LONG
Sep 18. 2020
30.84
Sep 29. 2020
36.69
7 Trading Days
18.98%
Link
LONG
Jun 15. 2021
21.07
Jun 30. 2021
23.33
11 Trading Days
10.75%
Link
LONG
Aug 5. 2021
24.90
Aug 23. 2021
28.12
12 Trading Days
12.94%
Link
LONG
Nov 19. 2021
24.45
Dec 16. 2021
29.17
18 Trading Days
19.32%
Link
Company Information
Stock Symbol
ZSL
Exchange
NASDAQ
Company URL
http://www.zosanopharma.com
Company Phone
510-745-1200
CEO
Konstantinos Alataris
Headquarters
California
Business Address
34790 ARDENTECH COURT, FREMONT, CA 94555
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001587221
About

Zosano Pharma Corp. is a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system. It offers rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that differentiate its delivery platform from other non-oral formulations or injections. The company was founded in January 2012 and is headquartered in Fremont, CA.

Description

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading